UnknownNot Applicable

18F-Fluorocholine PET/CT in Medullary Thyroid Cancer

Slovenia80 participantsStarted 2014-09-03

Plain-language summary

To assess the diagnostic accuracy of 18F-Fluorocholine PET/CT for the detection of medullary thyroid cancer in patients with primary and recurrent disease.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with medullary thyroid cancer (sporadic or hereditary form). * Patients with newly diagnosed MTC for primary staging (based on fine needle aspiration cytology results). * Patients with suspicion of MTC recurrence for re-staging (based on biochemical, conventional imaging or clinical examination). * Patients with metastatic MTC on systemic therapy for disease activity assessment. Exclusion Criteria: * Pregnancy. * Patient with any PET/CT-scan exam contraindication (eg. severe claustrophobia).

What they're measuring

Sensitivity, specificity, positive predictive value, negative predictive value and diagnostic accuracy in primary medullary thyroid cancer

Timeframe: 1 month

Sensitivity, specificity, positive predictive value, negative predictive value and diagnostic accuracy in recurrent medullary thyroid cancer

Timeframe: 3 months

Trial details

NCT IDNCT03643055

SponsorUniversity Medical Centre Ljubljana

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-03-03

View on ClinicalTrials.gov More Medullary Thyroid Cancer trials